• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Sequential hormone-chemotherapy (MAP at high doses and CMF) in metastatic breast cancer. Preliminary results.

作者信息

Pannuti F, Di Marco A R, Rossi A P, Rocchetta G, Rubino I, Giovannini M, Fruet F

出版信息

Panminerva Med. 1981 Apr-Jun;23(2):93-6.

PMID:6459558
Abstract
摘要

相似文献

1
Sequential hormone-chemotherapy (MAP at high doses and CMF) in metastatic breast cancer. Preliminary results.
Panminerva Med. 1981 Apr-Jun;23(2):93-6.
2
Monochemotherapy (Adriamycin) for metastatic breast cancer in progression after sequential hormone-chemotherapy (MAP and CMF). Pilot study.
Panminerva Med. 1981 Jan-Mar;23(1):25-8.
3
Cyclophosphamide, methotrexate and fluorouracil (CMF) versus hormonal ablation with leuprorelin acetate as adjuvant treatment of node-positive, premenopausal breast cancer patients: preliminary results of the TABLE-study (Takeda Adjuvant Breast cancer study with Leuprorelin Acetate).环磷酰胺、甲氨蝶呤和氟尿嘧啶（CMF）与醋酸亮丙瑞林激素去势作为淋巴结阳性绝经前乳腺癌患者辅助治疗的比较：TABLE研究（武田醋酸亮丙瑞林辅助乳腺癌研究）的初步结果
Anticancer Res. 2002 Jul-Aug;22(4):2325-32.
4
Mitoxantrone, 5-fluorouracil, and high dose leucovorin (NFL) versus intravenous cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) in first-line chemotherapy for patients with metastatic breast carcinoma: a randomized phase II trial.米托蒽醌、5-氟尿嘧啶和高剂量亚叶酸钙（NFL）与静脉注射环磷酰胺、甲氨蝶呤和5-氟尿嘧啶（CMF）用于转移性乳腺癌患者一线化疗的比较：一项随机II期试验。
Cancer. 1997 Feb 15;79(4):740-8.
5
Effectiveness of intermediate-dose methotrexate and high-dose 5-fluorouracil as sequential combination chemotherapy in refractory breast cancer and as primary therapy in metastatic adenocarcinoma of the colon.
Cancer Treat Rep. 1980 Aug-Sep;64(8-9):829-35.
6
[Clinical evaluation of cyclophosphamide, methotrexate and 5-fluorouracil (CMF) on advanced and recurrent breast cancer. Clinical study group of CMF for breast cancer in Japan].环磷酰胺、甲氨蝶呤和5-氟尿嘧啶（CMF）治疗晚期及复发性乳腺癌的临床评估。日本CMF乳腺癌临床研究组
Gan To Kagaku Ryoho. 1994 Sep;21(12):1949-56.
7
CCNU, melphalan, methotrexate, and prednisone (CAMP) versus cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) in the treatment of advanced breast cancer in postmenopausal women.环磷酰胺、美法仑、甲氨蝶呤和泼尼松（CAMP）与环磷酰胺、甲氨蝶呤和5-氟尿嘧啶（CMF）治疗绝经后妇女晚期乳腺癌的疗效比较
Cancer Treat Rep. 1980 Apr-May;64(4-5):635-7.
8
[Combined drug/hormone therapy in metastatic breast cancer with vincristine, adriamycin, cyclophosphamide and high dose medroxyprogesterone acetate--VAC-MAP. Preliminary results of a phase II study of the German Cancer Society's Internal Medicine Oncology Task Force].
Onkologie. 1982 Aug;5 Suppl:8-12.
9
[Primary chemotherapy of metastatic breast carcinoma with bendamustine hydrochloride, methotrexate and fluorouracil versus cyclophosphamide, methotrexate and fluorouracil].
Zentralbl Chir. 1998;123 Suppl 5:156-8.
10
Concurrent cyclophosphamide, methotrexate, and 5-fluorouracil chemotherapy and radiotherapy for breast carcinoma: a well tolerated adjuvant regimen.环磷酰胺、甲氨蝶呤和5-氟尿嘧啶同步化疗及放疗用于乳腺癌：一种耐受性良好的辅助治疗方案。
Cancer. 2002 Aug 15;95(4):696-703. doi: 10.1002/cncr.10744.